期刊文献+

GPC3、GS、HSP70在肝细胞癌中的表达及意义 被引量:7

Expression of GPC3,GS,HSP70 in hepatocelluar carcinoma
下载PDF
导出
摘要 目的研究免疫组织化学套餐磷脂酰肌醇蛋白聚糖-3(glypican-3,GPC3)、热休克蛋白70(heat shock protein70,HSP70)、谷氨酰胺合成酶(glutamyne synthetase,GS)在肝细胞癌(HCC)诊断中的应用。方法对85例HCC进行组织学观察,病理学分级;免疫组织化学方法检测上述病例中GPC3、GS、HSP70的表达情况。结果 85例HCC病例中,GPC3阳性表达率为88.24%(75/85),GPC3在肝细胞癌的阳性表达率随着分化的升高而递增,高分化与中低分化者GPC3的表达差异有统计学意义,与分化程度相关,其中7例可见癌旁再生结节个别细胞阳性表达;85例中80例HSP70均有不同程度的阳性表达,与HCC分化无明显相关,3例癌周组织中可见汇管区周围肝细胞着色;GS在HCC及周围肝组织的表达方式不同,HCC中有67.06%(57/85)阳性表达,GS的阳性表达与分化无明显相关性。结论 HSP70、GS、GPC3 3个指标的应用对于HCC的诊断具有各自的优点和缺点,在日常工作中,需在HE形态学基础上,结合上述3个指标的分布特点和表达强弱综合评估,免疫组化指标的应用可以进一步提高HCC诊断的可靠性。 Objective To evaluate the application of Glypican 3(GPC3),heat shock protein 70(HSP70) and glutamine synthetase(GS) in hepatocellular carcinoma.Methods Morphology of 85 cases of HCC were evaluated;three immunohistochemical markers-GPC3,GS,HSP70 were detected in these cases.Results In the 85 HCC cases,GPC3 was positive in 88.24%(75/85) cases and its expression was higher in poorly differentiation HCC than that in well/moderately differentiated HCC,the expression difference was statistically significant,individual cells in regenerative nodules adjacent HCC were GPC3 positive in 7 HCC;HSP70 was positive in 94.12%(80/85) cases,their expression had no significant correlation with HCC differentiation,and individual cells in regenerative nodules adjacent HCC were positive in 3 HCC;GS expression had different distribution modes between HCC and surrounding liver tissues,GS was positive in 67.06%(57/85) HCC and its expression had no significant correlation with HCC differentiation.Conclusion HSP70,GS,GPC3 for the diagnosis of HCC have their own advantages and disadvantages respectively.In daily work,diagnosis should base on HE morphology,and application of a panel of immunohistochemistry markers which can further improve the reliability of HCC diagnosis.
出处 《胃肠病学和肝病学杂志》 CAS 2011年第8期727-730,共4页 Chinese Journal of Gastroenterology and Hepatology
基金 首都医学发展科研基金(2007-3052)
关键词 肝细胞癌 磷脂酰肌醇蛋白聚糖-3 热休克蛋白70 谷氨酰胺合成酶 Hepatocellular carcinoma Glypican-3 Heat shock protein 70 Glutamyne synthetase
  • 相关文献

参考文献12

  • 1苏勤.对人肝细胞癌前期病变的新认识(上)[J].中国医刊,2006,41(11):9-10. 被引量:5
  • 2Nassar A, Cohen C, Siddiqui MT. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies [ J] . Diagn Cytopathol, 2009, 37 (9) : 629-35.
  • 3缪辉来,谢贵林,温继育,陈念平,陈明,包仕廷.Glypican-3蛋白在肝细胞癌患者血清和组织中的表达及意义[J].世界华人消化杂志,2007,15(21):2311-2315. 被引量:13
  • 4吴明健(综述),李军锋(综述),周育森(审校).Glypican-3作为检测肝细胞癌新标志物的研究进展[J].中国卫生检验杂志,2007,17(10):1907-1909. 被引量:6
  • 5Shirakawa H, Suzuki H, Shimomura M, et al. Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma [ J ]. Cancer Sci, 2009, 100(8) : 1403-1407.
  • 6Di Tommaso L, Destro A, Seok JY, et al. The application of markers ( HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepa- tocellular carcinoma [J]. J Hepatol, 2009, 50(4) : 746-754.
  • 7Chuma M, Sakamoto M, Yamazaki K, et al. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma [ J] . Hepatology, 2003, 37 ( 1 ) : 198-207.
  • 8Di Tommaso L, Franchi G, Park YN, et al. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cir- rhosis [J]. Hepatology, 2007, 45(3): 725-734.
  • 9Reitzer LJ, Wice BM, Kennell D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells [J]. J Biol Chem, 1979, 254(8): 2669-2676.
  • 10Audard V, Grimber G, Elie C, et al. Cholestasis is a marker for hep- atocellular carcinomas displaying beta-catenin mutations [ J ]. J Pathol, 2007, 212 ( 3 ) : 345-352.

二级参考文献52

共引文献36

同被引文献43

  • 1张影,綦盛麟,程宁,张勇.经典的Wnt信号通路在大鼠肝脏卵圆细胞增殖和分化中的作用[J].中华临床医师杂志(电子版),2011,5(15):4324-4330. 被引量:4
  • 2Jiang Long,Zhen-Wei Lang,Hua-Guang Wang,Tai-Ling Wang,Bao-En Wang and Si-Qi Liu Liver Research Center,Beijing Friendship Hospital, Capital Medical University,Beijing 100050,China,Department of Hepatology,Department of Pathology, Beijing Youan Hospital,Capital Medical University,Beijing 100069,China,Department of Pharmaceutical Affairs,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China,Department of Pathology,China-Japan Friendship Hospital,Beijing 100029,China,Beijing Genomics Institute,Chinese Academy of Science,Beijing Airport Industrial Zone B-6,Shunyi,Beijing 101300,China.Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected smal hepatocel ular carcinomas[J].Hepatobiliary & Pancreatic Diseases International,2010,9(3):296-305. 被引量:21
  • 3Jin G Z,Li Y,Cong W M,Yu H,Dong H,Shu H,et al. ITRAQ- 2DLC-ESI-MS/MS based identification of a new set of immunohis- tochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma [ J ]. Prot eome Res, 2011,10 : 3418 3428. htt p : / / pubs. acs. org/ doi/ suppl/10. 1021/pr200482t / suppl _file/ pr200482t_si_O01, pd f.
  • 4LuXY,XiT,LauWY,DongH,ZhuZ,ShenF,etal. Hepato- cellular carcinoma expressing cholangiocyte phenotype is a no vel subtype with highly aggressive behavior [J].Ann Surg On- eol,2011,18:2210-2217.
  • 5Penning T M, Drury J E. Human aldo-keto reductases: func- tion,gene regulation,and single nueleotide polymorphisms[J]. Arch Bioehem Biophys, 2007,464 : 241-250.
  • 6Zeindl-Eberhart E,Klugbauer S, Dimitrijevic N,Jungblut P R, Lamer S, Rabes H M. Proteome anaylsis of rat hepatomas:car- cinogen-dependent tumor-associated protein variants[J]. Elec- trophoresis, 2001,22 : 3009-3018.
  • 7Woenckhaus M, Klein-Hitpass L,Grepmeier U, Merk J, PIeifer M,Wild P,et al. Smoking and cancer related gene expression in bronchial epithelium and non-small-cell lung cancers [J]. J Pathol,2006,210: 192-204.
  • 8Fukumoto S, Yamauchi N, Moriguchi H, Hippo Y, Watanabe A,Shibahara J, et al. Overexpression of the aldokketo reductase family protein AKR1B10 is highly correlated with smokers' non-smallcell lung carcinomas[J].Clin Cancer Res, 2005, 11: 1776-1785.
  • 9Yoshitake H, Takahashi M, lshikawa H, Nojima M, lwanari H, Watanabe A, et al. Aldo-keto reductase family 1, member B10 in uterine carcinomas:a potential risk factor of recurrence after surgicaltherapy in cervical cancer[J]. Int J Gynecol Cancer, 2007,17 : 1300-1306.
  • 10Sun CK,Chua MS,He J,et al.Suppression of glypican 3 inhibitsgrowth of hepatocellular carcinoma cells through up-regulation of TGF-β2. Neoplasia . 2011

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部